Optimizing the efficacy of exposure in PTSD treatment

References

• Bontempo A., Panza K. E., Bloch M. H. D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: A meta-analysis. The Journal of Clinical Psychiatry. 2012; 73(4): 533–537. [PubMed Abstract] [PubMed CentralFull Text] doi: 10.4088/JCP.11r07356.
   Google Scholar
• Debiec J., Ledoux J. E. Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala. Neuroscience. 2004; 129(2): 267–272. [PubMed Abstract] doi: 10.1016/j.neuroscience.2004.08.018.
   Google Scholar
• De Kleine R. A., Hendriks G. J., Kusters W. J., Broekman T. G., Van Minnen A. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry. 2012; 71(11): 962–968. [PubMed Abstract] doi: 10.1016/j.biopsych.2012.02.033.
   Google Scholar
• De Kleine R. A., Hendriks G. J., Smits J. A., Broekman T. G., Van Minnen A. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research. 2014; 48(1): 40–46. [PubMed Abstract] doi: 10.1016/j.jpsychires.2013.10.008.
   Google Scholar
• De Kleine R. A., Rothbaum B. O., Van Minnen A. Pharmacological enhancement of exposure-based treatment in PTSD: A qualitative review. European Journal of Psychotraumatology. 2013; 4: 21626. http://dx.doi.org/10.3402/ejpt.v4i0.21626.
   Google Scholar
• Difede J., Cukor J., Wyka K., Olden M., Hoffman H., Lee F. S., etal. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: A pilot randomized clinical trial. Neuropsychopharmacology. 2014; 39(5): 1052–1058. [PubMed CentralFull Text] doi: 10.1038/npp.2013.317.
   Google Scholar
• Ipser J., Seedat S., Stein D. J. Pharmacotherapy for post-traumatic stress disorder—A systematic review and meta-analysis. South African Medical Journal. 2006; 96(10): 1088–1096. [PubMed Abstract].
   Google Scholar
• Kehle-Forbes S. M., Polusny M. A., MacDonald R., Murdoch M., Meis L., Wilt T. J. A systematic review of the efficacy of adding non exposure components to exposure therapy for posttraumatic stress disorder. Psychological Trauma: Theory, Research, Practice and Policy. 2012; 5(4): 317–322.
   Google Scholar
• Kindt M., Soeter M. Reconsolidation in a human fear conditioning study: A test of extinction as updating mechanism. Biological Psychology. 2013; 92(1): 43–50.
   Google Scholar
• Litz B. T., Salters-Pedneault K., Steenkamp M. M., Hermos J. A., Bryant R. A., Otto M. W., etal. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research. 2012; 46(9): 1184–1190. [PubMed Abstract] doi: 10.1016/j.jpsychires.2012.05.006.
   Google Scholar
• Marshall R. D., Lewis-Fernandez R., Blanco C., Simpson H. B., Lin S. H., Vermes D., etal. A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults. Depression and Anxiety. 2007; 24(2): 77–84. [PubMed Abstract] doi: 10.1002/da.20176.
   Google Scholar
• Norberg M. M., Krystal J. H., Tolin D. F. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry. 2008; 63(12): 1118–1126. [PubMed Abstract] doi: 10.1016/j.biopsych.2008.01.012.
   Google Scholar
• Olff M., Van Zuiden M., Koch S., Nawijn L., Frijling J., Veltman D. Intranasal oxytocin: Miracle cure after trauma?. European Journal of Psychotraumatology. 2015; 5: 27631. http://dx.doi.org/10.3402/ejpt.v5i0.27631.
   Google Scholar
• Powers M. B., Halpern J. M., Ferenschak M. P., Gillihan S. J., Foa E. B. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clinical Psychology Review. 2010; 30(6): 635–641. [PubMed Abstract] doi: 10.1016/j.cpr.2010.04.007.
   Google Scholar
• Rothbaum B. O., Cahill S. P., Foa E. B., Davidson J. R., Compton J., Connor K. M., etal. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder. Journal of Traumatic Stress. 2006; 19(5): 625–638. [PubMed Abstract] doi: 10.1002/jts.20170.
   Google Scholar
• Rothbaum B. O., Price M., Jovanovic T., Norrholm S. D., Gerardi M., Dunlop B., etal. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans. The American Journal of Psychiatry. 2014; 171(6): 640–648. [PubMed Abstract] doi: 10.1176/appi.ajp.2014.13121625.
   Google Scholar
• Schnurr P. P., Chard K. M., Ruzek J. I., Chow B. K., Shih M. C., Resick P. A., etal. Design of VA Cooperative Study #591: CERV-PTSD, comparative effectiveness research in veterans with PTSD. Contemporary Clinical Trials. 2014; 41C: 75–84. doi: 10.1016/j.cct.2014.11.017.
   Google Scholar
• Schnurr P. P., Friedman M. J., Engel C. C., Foa E. B., Shea M. T., Chow B. K., etal. Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial. JAMA. 2007; 297(8): 820–830. [PubMed Abstract] doi: 10.1001/jama.297.8.820.
   Google Scholar
• Simon N. M., Connor K. M., Lang A. J., Rauch S., Krulewicz S., LeBeau R. T., etal. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. The Journal of Clinical Psychiatry. 2008; 69(3): 400–405.
   Google Scholar
• Watts B. V., Schnurr P. P., Mayo L., Young-Xu Y., Weeks W. B., Friedman M. J. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. The Journal of Clinical Psychiatry. 2013; 74(6): 541–550. doi: 10.4088/JCP.12r08225.
   Google Scholar